Professor Winter elected Fellow, Biomedical Engineering Society
On the heels of being named a fellow of the internationally-renowned Royal Society of Chemistry (RSC), Professor Jessica Winter has been elected to the Biomedical Engineering Society (BMES) 2021 BMES Class of Fellows.
BMES awards fellow status to members who demonstrate exceptional achievements and experience in the field of biomedical engineering, and who hold a record of membership and participation in the Society.
"We thank you for your contributions and hope you continue to blaze the path for future BMEs," wrote John White, BMES President and Professor and Chair of Boston University, in informing Professor Winter that she had been elected.
"I am humbled and honored to receive this news," Winter said in learning of the news.
The 2021 Class of Fellows will be recognized during the BMES Annual Meeting held October 6-9, 2021.
Winter, an established leader in nanobiotechnology, has served as an associate editor of RSC's Journal of Materials Chemistry B for several years.
Winter's primary research interest is the exploration of the relationship between nanoparticles and biological elements. In August 2020 she was honored with the prestigious Jacobus van 't Hoff Lectureship at the University of Delft, Netherlands, where she gave a talk entitled "Encapsulating Hydrophobic Cargoes in Micelles via Scalable Nanomanufacturing Approaches."
Her experience with scalable nanomanufacturing has grown as a result of her Quantum Dot imaging innovation, a high-caliber magnetic fluorescent nanoparticle which shines in different colors to tag molecules in biomedical tests such as cancer detection. After finding evidence that the refined particle could help researchers to significantly reduce costs, increase the efficiency of their research, better identify and understand disease progression, and improve patient outcomes, she founded a start-up company, Core Quantum Technologies, LLC, which is working towards providing the substantially-improved quantum dot and magnetic dot products to the research biotechnology market.
